iRadimed Corp (NAS:IRMD)
$ 43.22 1.07 (2.54%) Market Cap: 547.35 Mil Enterprise Value: 490.99 Mil PE Ratio: 30.65 PB Ratio: 7.19 GF Score: 95/100

Q4 2019 IRadimed Corp Earnings Call Transcript

Feb 06, 2020 / 04:00PM GMT
Release Date Price: $26.88 (+4.96%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the IRADIMED Corporation Fourth Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded today, February 6, 2020, and contains time-sensitive information that is accurate only as of today.

Earlier, IRADIMED released financial results for the fourth quarter 2019. A copy of this press release announcing the company's earnings is available under the heading News on their website at iradimed.com. A copy of the press release was also furnished to the Securities and Exchange Commission on Form 8-K and can be found at sec.gov. This call is being broadcast live over the Internet on the company's website at iradimed.com, and a replay of the call will be available on the website for the next 90 days.

The agenda for today's call will be as follows: Leslie McDonnell, President and Chief Executive Officer of IRADIMED, will present opening comments; then Brent Johnson, IRADIMED's Executive Vice President of Worldwide Sales and Marketing, will discuss customer orders; and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot